Skip to main content
. 2022 Nov 1;38(1):176–191. doi: 10.1080/14756366.2022.2135512

Figure 4.

Figure 4.

Schematic illustration disclosing the pharmacophoric features of the afforded pyrimidine and pyridine derivatives as EGFRIs.